000			01958 a2200553 4500
005			20250517072251.0
264		0	_c20160601
008			201606s 0 0 eng d
022			_a1095-6859
024	7		_a10.1016/j.ygyno.2015.12.020 _2doi
040			_aNLM _beng _cNLM
100	1		_aDomchek, Susan M
245	0	0	_aEfficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. _h[electronic resource]
260			_bGynecologic oncology _cFeb 2016
300			_a199-203 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aGenes, BRCA1
650	0	4	_aGenes, BRCA2
650	0	4	_aGerm-Line Mutation
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aOrganoplatinum Compounds _xpharmacology
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPhthalazines _xadverse effects
650	0	4	_aPiperazines _xadverse effects
650	0	4	_aPoly(ADP-ribose) Polymerase Inhibitors _xtherapeutic use
650	0	4	_aProspective Studies
700	1		_aAghajanian, Carol
700	1		_aShapira-Frommer, Ronnie
700	1		_aSchmutzler, Rita K
700	1		_aAudeh, M William
700	1		_aFriedlander, Michael
700	1		_aBalmaña, Judith
700	1		_aMitchell, Gillian
700	1		_aFried, Georgeta
700	1		_aStemmer, Salomon M
700	1		_aHubert, Ayala
700	1		_aRosengarten, Ora
700	1		_aLoman, Niklas
700	1		_aRobertson, Jane D
700	1		_aMann, Helen
700	1		_aKaufman, Bella
773	0		_tGynecologic oncology _gvol. 140 _gno. 2 _gp. 199-203
856	4	0	_uhttps://doi.org/10.1016/j.ygyno.2015.12.020 _zAvailable from publisher's website
999			_c25593005 _d25593005